+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

Hepatitis B Vaccine Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Hepatitis B Vaccine Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 146 Pages
  • Global
From
LAG-3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Akt1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Akt1 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Natamycin Market 2022-2026 - Product Thumbnail Image

Natamycin Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
From
Hyperinsulinemia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hyperinsulinemia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 93 Pages
  • Global
From
CAR-T - Pipeline Insight, 2025 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Thymus Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thymus Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator